{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:55:05Z","timestamp":1791251705670,"version":"4.1.0"},"reference-count":62,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      End stage kidney disease (\n                      <jats:styled-content style=\"fixed-case\">ESKD<\/jats:styled-content>\n                      ) is associated with a high prevalence of depression and anxiety, arising from both biological factors and the psychosocial burden of chronic dialysis care. Approximately 25%\u201330% of dialysis patients experience clinically significant depressive symptoms when assessed by structured clinical interview, though reported prevalence varies widely by assessment method. These disorders negatively impact adherence, hospitalization rates, and mortality, with diagnostic challenges arising from overlapping uremic symptoms and reliance on self\u2010report tools. Biological contributors such as uremia, anemia, chronic inflammation, and polypharmacy, together with social stressors including unemployment, isolation, and financial hardship, exacerbate psychiatric vulnerability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Randomized trials demonstrate that cognitive behavioral therapy (\n                      <jats:styled-content style=\"fixed-case\">CBT<\/jats:styled-content>\n                      ) reduces depressive symptoms, improves quality of life, and enhances treatment adherence, and lessons from oncology and primary care support collaborative care models. However, dialysis centers often lack resources and are constrained by reimbursement policy. This narrative review synthesizes evidence across epidemiology, biopsychosocial mechanisms, pharmacotherapy considerations specific to renal impairment, and non\u2010pharmacologic interventions, and proposes a roadmap for integrated mental health care in dialysis that clearly distinguishes evidence\u2010based recommendations from expert opinion. Integrated, multidisciplinary approaches hold promise for enhancing patient well\u2010being and reducing the burden of mental illness in dialysis care.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hdi.70102","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:25:04Z","timestamp":1781652304000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mental Health Disorders in End\u2010Stage Kidney Disease: A Narrative Review of Clinical Considerations for Integrated Management"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3209-8140","authenticated-orcid":false,"given":"Kunal","family":"Malhotra","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine Saint Louis University  St. Louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Fangue\u2010Nelon","sequence":"additional","affiliation":[{"name":"Centerstone  Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Singh","sequence":"additional","affiliation":[{"name":"Centerstone  St. louis Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"1","key":"e_1_2_15_2_1","first-page":"19","article-title":"Definition and Classification of CKD","volume":"3","author":"Chapter\u00a01","year":"2011","journal-title":"Kidney International. Supplement"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.05.017"},{"key":"e_1_2_15_4_1","volume-title":"ESRD Quality Incentive Program: Depression Screening and Follow\u2010Up","author":"Centers for Medicare & Medicaid Services","year":"2023"},{"key":"e_1_2_15_5_1","unstructured":"American Kidney Fund \u201cMental Health and Kidney Disease \u201d2024."},{"key":"e_1_2_15_6_1","volume-title":"Depression and Kidney Disease","author":"American Kidney Fund","year":"2022"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012111134"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041599.x"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2009.00628.x"},{"key":"e_1_2_15_10_1","volume-title":"Standards of Practice for Nephrology Social Workers","author":"Browne T.","year":"2014"},{"issue":"73","key":"e_1_2_15_11_1","first-page":"20369","article-title":"Medicare and Medicaid Programs; Conditions for Coverage for End\u2010Stage Renal Disease Facilities. Final Rule","volume":"73","author":"Centers for Medicare & Medicaid Services (CMS), HHS","year":"2008","journal-title":"Federal Register"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.02.001"},{"key":"e_1_2_15_13_1","volume-title":"Chronic Kidney Disease in the United States, 2023","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2025.02.602"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05540420"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.77"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012050536"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00040107"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10261013"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.025"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.akdh.2023.09.005"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01005-1"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.07.001"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17131"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2229"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44192-025-00163-z"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115467"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs295"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2018-0264"},{"key":"e_1_2_15_30_1","unstructured":"U.S. Food and Drug Administration \u201cFDA Drug Safety Communication: Revised Recommendations for Celexa (Citalopram Hydrobromide) Related to a Potential Risk of Abnormal Heart Rhythms with High Doses \u201dMarch 28 2012."},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000078635"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018101032"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.82"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.2017474"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05021"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.20519"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2006.10.008"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2007.01963.x"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.156"},{"issue":"8","key":"e_1_2_15_40_1","first-page":"VC06","article-title":"Cognitive Behaviour Therapy for Anxiety and Depression Among People Undergoing Haemodialysis: A Randomized Control Trial","volume":"10","author":"Valsaraj B. P.","year":"2016","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/papt.12098"},{"key":"e_1_2_15_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2018.07.012"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0391398818823765"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2016.08.012"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/00981389.2018.1523268"},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.2018.37.1.77"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000629"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20701"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3650"},{"key":"e_1_2_15_50_1","volume-title":"Depression in Adults: Treatment and Management","author":"National Institute for Health and Care Excellence","year":"2022"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063095"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.22.2836"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.112"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"issue":"4","key":"e_1_2_15_55_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/NDT.A798","article-title":"Combination\/Augmentation Strategies for Improving the Treatment of Depression","volume":"1","author":"Moret C.","year":"2005","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/clipsy.8.1.98"},{"key":"e_1_2_15_57_1","volume-title":"The Theory and Practice of Group Psychotherapy","author":"Yalom I. D.","year":"2020"},{"key":"e_1_2_15_58_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2019.207"},{"key":"e_1_2_15_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25068-7"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1030630"},{"key":"e_1_2_15_61_1","unstructured":"Centers for Medicare & Medicaid Services \u201cESRD Prospective Payment System \u201d2024."},{"key":"e_1_2_15_62_1","unstructured":"Centers for Medicare & Medicaid Services \u201cMedicare Program; End\u2010Stage Renal Disease Prospective Payment System Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury and End\u2010Stage Renal Disease Quality Incentive Program (CY 2025) \u201d2024."},{"key":"e_1_2_15_63_1","volume-title":"Report to the Congress: Medicare and the Health Care Delivery System, Chapter\u00a06 \u2013 Improving Medicare's Payment for Outpatient Behavioral Health Services","author":"Medicare Payment Advisory Commission","year":"2023"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hdi.70102","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hdi.70102","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hdi.70102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:46:56Z","timestamp":1791251216000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hdi.70102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/hdi.70102"],"URL":"https:\/\/doi.org\/10.1111\/hdi.70102","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"2025-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}